This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday
Author: Avi Kapoor | January 03, 2025 12:53pm
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
William Blair analyst Andy Hsieh initiated coverage on Elevation Oncology, Inc. (NASDAQ:ELEV) with an Outperform rating. Elevation Oncology shares closed at $0.5951 on Thursday. See how other analysts view this stock.
William Blair analyst Sarah Schram initiated coverage on Denali Therapeutics Inc. (NASDAQ:DNLI) with an Outperform rating. Denali Therapeutics shares closed at $20.84 on Thursday. See how other analysts view this stock.
Considering buying DNLI stock? Here’s what analysts think:
